Ostreogrycin G,
Pristinamycin IIA,
Pristinamycin IIB,
Staphylomycin M,
Staphylomycin M1,
Streptogramin A,
Virginiamycin Factor M1,
Virginiamycin IIB,
Virginiamycin M1,
virginiamycin m1,
Streptogramin A,
Mikamycin A,
Pristinamycin IIA,
Ostreogrycin a,
UNII-8W4UOL59AZ,
8W4UOL59AZ,
21411-53-0,
Virginiamycin Factor M1,
CHEBI:9997,
NSC 244426,
VERNAMYCIN A,
Staphylomycin M1,
NSC87434,
EINECS 244-376-6,
NSC 87432,
Factor M,
Virginiamycin M1-dx,
Antibiotic PA 114A1,
Vernamycin A & B mixture,
Virginiamycin M1 (90%),
SCHEMBL673193,
CHEMBL1236670,
PA 114A,
DAIKHDNSXMZDCU-FQTGFAPKSA-N,
8,9,14,15,24,25-Hexahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone,
8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone,
MFCD00869411,
NSC-87434,
Vernamycin A & vernamycin B (1:1),
DB01669,
Vernamycin A, mixture with vernamycin B,
RP 12536,
VERNAMYCIN A & B MIXTURE (1:1),
LS-187695,
C11299,
C-23077,
UNII-4O8O7Q7IU4 component DAIKHDNSXMZDCU-FQTGFAPKSA-N,
(3R,4R,5E,10E,12E,14S)-14-hydroxy-3-isopropyl-4,12-dimethyl-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone,
(3R,4R,5E,10E,12E,14S)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone,
(3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone,
Staphylomycin,
Virginiamycin M,
VIRGINIAMYCINM1,
VIR,